Helen Routh, PhD
Specialty in AI Innovation
Dr. Routh is the Non-executive Chair of the Board at Ultromics, an AI-based ultrasound diagnostic support tool for coronary artery disease. She is also a Non-Executive Director at the Agfa-Gevaert Group, who develops, produces and distributes an extensive range of analog and digital imaging systems and IT solutions and at Health Innovation Manchester, a. Dr. Routh has extensive professional history in healthcare innovation, strategy and business for Royal Philips.
Practice names
2018 - Present - Chairman, Ultromics
2019 - Present - Non-Executive Director, AGFA-Gevaert Group
2019 - Present - Non-Executive Director, Health Innovation Manchester
2020 - Present - Medical Advisory Board Member, Buoy Health
2015 - 2017 - Head of Integrated Solutions, SVP Strategy & Innovation
Education and training
1983 - 1987 - PhD, Physics (Medical Ultrasound), University College Cardiff, Wales
1984 - 1985 - EE, University of Illinois at Urbana-Champaign
1980 - 1983 - BS (Physics & Music), University College Cardiff, Wales